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The catch-22 of the COVID-19 “lockdown”
To the Editor
The turn of the year marked the ominous 
birth of what later developed into a pandemic. 
The Chinese city of Wuhan reported a cluster of 
44 cases of pneumonia which had an unknown 
etiology [1]. The offending agent was later found 
to be a novel coronavirus, the third of its type to 
cause a major outbreak in humans over the past 
two decades following SARS and MERS. The 
resulting disease was later named COVID-19 [2]. 
The virus’ high rate of infectivity in a city of 
almost 10 million people led to a rapid and expo-
nential growth of cases. The healthcare system 
quickly became overwhelmed and the Chinese 
government responded by imposing a lockdown. 
The aim was straight-forward: to stagger the expo-
nential growth of new cases and thus “flatten the 
curve” [3]. This allowed the healthcare system to 
have some more flexibility in order to respond to 
the huge number of patients. 
India identified its first case on 30th January 
2020 [4]. The patient was a student returning 
from the city of Wuhan. With an ever-increasing 
number of cases being diagnosed over the coming 
weeks, countries further imposed travel restric-
tions and closed international borders to prevent 
the spread of the disease. This initial measure 
only delayed the unavoidable and many countries 
began to see a rapid increase in cases. Local trans-
mission played a significant role in this increase. 
Consequently, on March 11th, 2020, the World 
Health Organization declared that COVID-19 was 
a “pandemic” [2]. Over the next 10 days, India 
noticed the beginning of an exponential upstroke 
in cases. The goal of the Government of India 
was to “stagger the cases” and “flatten the curve”. 
Therefore, they responded by initiating an unpre-
cedented nationwide lockdown which brought all 
non-essential services to a halt.
The flip side of the coin
In absence of a definitive treatment or an 
effective vaccine, lockdown and social distancing 
are the two weapons to combat this pandemic. 
The aim behind the lockdown was to contain 
the spread and to upscale healthcare facilities 
in order to better manage the potential “flood” 
of cases. Another merit of this plan was that it 
would theoretically allow for healthcare research 
teams to come up with an effective curative and/or 
prophylactic treatment plan. The strategy has ar-
guably worked, with the number of new cases out-
side of “hotspot areas” not showing a disastrous 
increment. There are, however, unsolicited effects 
that bear considerable relevance in a country with 
limited resources. 
A double-edged sword
State governments throughout India have 
designated major tertiary care hospitals to speci-
fically manage COVID-19. Medical subspecialty 
services in the Indian public health setup are 
extremely scarce outside of tertiary care cen-
ters. A vast majority of super specialty and sub-
specialty services in India are limited to tertiary 
care centers. In most of these hospitals, routine 
out-patient services have been halted with only 
emergency services being delivered. In addition, 
resident doctors of these specialties have been 
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diverted to perform COVID-19 duties in order 
to form a large pool of health care professionals 
(HCP) that are focused on this specific medical 
issue. This was largely done to maximize the treat-
ment of the huge number of COVID-19 patients as 
well as to have adequate backup in the unfortunate 
event that frontline HCPs were to get infected. 
Further, planned medical procedures and surgeries 
have been postponed for the foreseeable future. 
Hospitals have been advised to discharge all pa-
tients who are not very ill in order to create space 
for COVID-19 patients. These steps also contribute 
towards decreasing potential cross-infection.
A majority of India’s 1.3 billion population 
belong to low/middle-income groups which 
mainly utilize public health services for their 
health needs. These people also depend on go-
vernment provisions for disease-related follow-up 
and pharmacological re-fills. This fact is further 
compounded by the country’s high prevalence 
of diseases such as hypertension, coronary ar-
tery disease, diabetes mellitus, cataract, chronic 
obstructive pulmonary disease, tuberculosis, 
and various malignancies [5]. Considering the 
above-mentioned information, it is important to 
note that long duration lockdowns carry a risk of 
aggravating and losing control of the treatment 
of chronic illnesses. Financial constraints also 
inhibit the use of home-based monitoring devices 
which further heightens the risk. 
Logic and logistics
The interconnected digital world has spread 
awareness about preventative measures against an 
infective pandemic disease more effectively and 
quickly than at any time in the past. To HCP’s, 
avoiding hospital contact during this trying time 
has become fundamentally and logically perti-
nent. The ‘nation’ may be under lockdown, but 
the “disease” isn’t. Even when people fall ill from 
diseases other than COVID-19, they will tend to 
avoid hospital contact. This has mostly been seen 
in patients experiencing acute coronary syndromes 
and cerebrovascular incidents. They may either 
ignore symptoms, consult local health services for 
symptomatic treatment, or even self-medicate. In 
doing so, an essential evaluation of symptoms that 
may require special tests is not completed. In ad-
dition, the majority of low/middle-income house-
holds primarily use affordable public transport 
systems. For people seeking care in public hospi-
tals, the curbs on transport create a hurdle in their 
ability to physically be able to get to well-equipped 
centers culminating in treatment delay. 
A receding ocean before the tsunami
During the periods of lockdown, stable pa-
tients with chronic diseases have been advised 
to stay at home and avoid going to hospitals for 
routine follow up. Patients requiring non-urgent 
care have been asked to wait and routine proce-
dures/surgeries have also been put on hold. In 
addition to this, patients are avoiding hospital 
visits with a fear of contracting COVID-19. As 
a result, the number of these patients is accumu-
lating. Once the lockdown restrictions are taken 
down, the flood of patients will undoubtedly 
put the health care system, which may already 
be depleted, in further distress. In addition, the 
lockdown hampers the economy of the country 
as a whole which can lead to an economic cri-
sis. This will further impair our spending on 
strengthening healthcare services, purchasing 
testing kits, and funding the purchase of equip-
ment and drugs.
The benefit of a nationwide “lockdown” 
has its positives and negatives. It has dampe-
ned the potential explosion of COVID-19 ca-
ses in countries such as India and Singapore. 
However, its doubtless effect on patients with 
non-COVID-19 illnesses is worrisome. A pro-
longed lockdown which will seemingly benefit 
COVID-19 containment will also impair patients 
with other diseases. As such, this period cannot 
be indefinite. India has slowly but progressively 
managed to reduce the morbidity and mortality 
resulting from “disease” in general. It is prudent 
to address this catch-22 situation extensively 
and promptly or else the good work that has 
been accomplished up to this point may be 
tarnished. 
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